A Study of LY2979165 in Healthy Subjects

NCT01383967 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: LY2979165
DRUG: placebo

Sponsor

Eli Lilly and Company